Introduction
The glymphatic-lymphatic system plays an important role in the clearance of extracellular metabolites and waste products in the brain 1 , 2 . The glymphatic (glial-lymphatic) is a postulated system for the CSF-interstitial fluid (ISF) exchange in the brain driven by the CSF influx force, which moves solutes from the periarterial CSF space via ISF efflux to the perivenous CSF space 3, 4 . Due to this glymphatic flow, waste solutes travel though meningeal lymphatic system to the outside the brain, which are drained to dCLN 1 . The glymphaticlymphatic system of CSF influx and ISF efflux show changes with aging and several neurological disorders such as Alzheimer's disease (AD), subarachnoid hemorrhage, stroke, and traumatic brain injury (TBI) 2, 5 . Glymphatic-lymphatic clearance system maintains homeostasis in the brain, but its disturbance could yet be knowingly manipulated by any method in pre-clinical or clinical studies.
FUS provides ultrasonic energy to a small volume of the target tissues non-invasively. The interaction of FUS and MB that are injected in the blood vessel can stimulate the vascular endothelium to mechanically open the blood-brain barrier (BBB) for several hours 6 and it has been used as a tool for drug delivery to the brain across the BBB. However, interestingly without any drugs delivery, FUS-MB in AD model reduced the deposition of Aβ and tau, improved memory, and increased internalization of Aβ in microglia [7] [8] [9] . These effects were mostly considered to be due to BBB opening, while assuming that brain-resident cells disposed on site within the brain all the abnormal proteins such as Aβ or tau 9, 10 . We propose that the FUS-MB shows effects on the waste disposal from the brain parenchyma to CSF and then lymphatics in this investigation. This effect might have improved the behavioral impairment in the previous mouse experiments [7] [8] [9] [10] . Based on these therapeutic effects, a single-arm, non-randomized phase 2 trials have been recently performed to evaluate the efficacy of FUS-MB in AD patients 6 . As the applications in clinical practice are important, it is also necessary to investigate the mechanism of the effects.
In this study, we investigated that the cause of Aβ reduction in the whole brain of 5XFAD 
Results

Aβ reduction by FUS-MB in the entire brain further to the target regions
The BBB opening induced by FUS-MB around the ipsilateral hippocampus was confirmed by
Evans blue staining (Fig. 1a) . FUS-MB in 5XFAD mice reduced amyloid deposition in the contralateral hemisphere as well as in the ipsilateral regions (Fig. 1c) . Immunohistochemistry of Aβ on the serial sections of the entire brain of mice treated with FUS-MB (n=6) showed the reduction of total area of Aβ deposits in brain region not directly targeted by FUS-MB (Fig. 1d) . As a result of immunostaining with antibodies for microglial marker Iba1 (ionized calcium binding adaptor molecule 1) and reactive astrocytic marker GFAP (glial fibrillary acidic protein), it was shown that FUS-MB reduced gliosis in the hippocampus and entorhinal cortices, contralateral as well as ipsilateral (Fig. 1e ). In the wild type mice, microglia activation was also decreased by FUS-MB (Fig. 1e) . Therefore, FUS-MB reduced amyloid deposits and ameliorated glial activation in the entire brain.
FUS-MB improved solute Aβ clearance but not plaques
The lymphatic system in the CNS plays a role in drainage of solute wastes through CSF, and the lymphatic system damage causes amyloid deposition 2 . Ligation of lymphatics to dCLN was performed to reveal its blocking effect upon Aβ and plaques in the entire brain by FUS-MB which increases Aβ clearance to the CSF space. The 6E10 positive Aβ amyloid deposits were significantly decreased by FUS-MB in 5XFAD and dCLN-ligated 5XFAD compared to their controls, respectively (Fig. 2b, c) . Thioflavin S (ThS) positive amyloid plaques increased the areas after the lymphatics ligation in dCLN ligation compared to non-ligation group of 5XFAD. ThS positive amyloid plaques did not decrease after FUS-MB in nonliagtion group of 5XFAD (Fig. 2d, e) . When the changes after FUS-MB and/or dCLN ligation, FUS-MB decreased Aβ areas but not the areas of amyloid plaques (Fig. 2f ). This finding suggested that FUS-MB inhibited plaque formation by decreasing ambient Aβ quantity in the brain and it is probably due to the increased drainage of solute Aβ. These findings support that amyloid plaques are waste depository where the surplus Aβ resided in the brain due to insufficient/ blocked clearance, rather than stopping to go outside of the brain.
CSF Aβ drainage by FUS-MB via meningeal lymphatics
The concentration of CSF Aβ was measured in the 5XFAD mice with or without dCLN ligation to reveal the effect of lymphatic obstruction on CSF drainage of solute Aβ.
Compared to 5XFAD without FUS-MB, the concentration of CSF Aβ 1-42 slightly elevated with FUS-MB in non-ligation group (Fig. 3a) . Here, dCLN ligation increased CSF Aβ 1-42 and much further by FUS-MB (Fig. 3a) . This indicates that CSF Aβ 1-42 are cleared through meningeal lymphatics draining to dCLNs.
On immunohistochemistry, while dCLN ligation showed rare Aβ in meningeal perivascular spaces, FUS-MB induced the prominent accumulation along the meningeal peirarterial and perivenous spaces. This accumulation was exaggerated by FUS-MB in dCLN ligation group (Fig. 3b) . It was interpreted that solute Aβ were snapshot while stuck in perivascular spaces due to the back-pressure of lymphatic outflow obstruction. However, it is not certain that Aβ are just leaving or staying in the neighbor of meningeal vessels.
Working memory by dCLN ligation and/or FUS-MB in 5XFAD mice
By dCLN ligation, 5XFAD mice suffered from the impairment of working memory, which was significantly improved by FUS-MB (Fig. 3c) . Plaque burden, represented by ThS stained area (ThS area), was not correlated (p=0.37,n=29) with the alternation % of the Y-Maze tests (Fig. 3d, Supplementary Fig. 2 ). However, there was the tendency that ThS area was lower in dCLN ligation with FUS-MB than in dCLN ligation only group. The ThS area was positively correlated (p=0.0005, n=29) with 6E10 positive Aβ amyloid deposits (Aβ area), and unlike the ThS area, Aβ area tended to be negatively correlated (p=0.15, n=31) with alternation % of Y-Maze (Fig. 3e, Supplementary Fig. 2 
Changes of brain cells by FUS-MB and/or dCLN ligation
The effects of FUS-MB on brain cells were examined to evaluate the changes on the cells which could be caused directly by FUS-MB or indirectly by the pathological changes. After dCLN ligation in entorhinal cortex, H&E and TUNEL staining revealed the loss of neurons which was rescued by FUS-MB (Fig. 4a) . Also, GFAP positive astrocytes increased and FUS-MB prevented this increase. In other areas such as dentate gyrus, CA1 and CA3 in hippocampus, no increase after dCLN ligation and no rescue by FUS-MB was observed ( Fig. 2a ). The only finding to explain the variability of memory performance on Y maze was the fact that it was working memory after FUS-MB in dCLN ligated groups (Fig. 3c ). Despite the amount of sustaining plaques similar to those of naïve 5XFAD, after FUS-MB treatment in dCLN ligation compared with naïve 5XFAD, the amount of plaques was significantly smaller than dCLN ligation (Fig. 3d, e) . Taken RAGE1 and LRP1 regulated Aβ levels in the brain and plasma 13 . Vascular smooth muscle actin was lost and smooth muscle cells degenerated in AD and these changes might be associated with decreased clearance through BBB. 14 FUS are yet to be found to influence these molecules. 3) Enhanced clearance of Aβ by glymphatic-lymphatic system. Aβ clearance increased in relation with non-REM sleep. Impairment of meningeal lymphatics induced amyloid accumulation, and AAV1-CMV-mVEGF-C treatment enhanced CSF drainage and meningeal lymphatics function and improved spatial learning and memory. 2 As water channel aquaporin-4 (AQP4) in astrocytic end feet plays a role in glymphatic flow and maintained CSF influx in Aqp4 knockout mice 15 . In AD, AQP4 were expressed abnormally and mislocalized. 16 FUS can also affect AQ4 and facilitate waste disposal by stimulating glymphatic-lymphatic system.
We decided to test the contribution of glymphatic-lymphatic system to explain the effect of FUS-MB on Aβ clearance. CSF Aβ concentration tended to increase in some animals after dCLN ligation, however, FUS-MB increased much CSF Aβ after dCLN ligation (Fig. 3a) .
FUS-MB was sure to dispose solute Aβ through the perivascular spaces into meningeal lymphatic vessels (Fig. 3b) . In other words, dCLN ligation disclosed the effect of FUS-MB upon glymphatic-lymphatic clearance. Interestingly, dCLN ligation resulted in the aggravation of memory impairment, but individual variation obscured the significant difference (Fig. 3c) . The beneficial effect of FUS-MB on memory dysfunction in naïve 5XFAD was also seen but with much variation. However, the effect of FUS-MB on dCLN ligation was prominent and thus significant (Fig. 3c) . dCLN ligation and consequent meningeal lymphatic blockage exaggerated the effect of FUS-MB on glymphatic-lymphatic system (Fig. 3c) . We suspect that the variation of memory impairment in 5XFAD syngeneic (Fig. 3a-c) . This effect of FUS-MB on memory function was evident in lymphatic ligation cases with the highest CSF Aβ concentrations (Fig. 3a, c) . Which cells or molecules are directly or indirectly influenced by FUS-MB are to be unraveled. Our results demonstrate that glymphatic-lymphatic system is involved and considering differential effect of FUS-MB on plaques and solute Aβ, it might be preferred that FUS-MB acts on solutes Aβ but not plaques (Fig. 2) . As the quantity of Aβ and plaques are expressed by Image J-derived areas and thus correlated with each other (38% of mutual explanatory power), the changes of plaques might (or might not) be observed in similar or dissimilar experiments of FUS. We propose that solute Aβ is the target of removal by glymphaticlymphatic system, deterred by dCLN ligation and facilitated by FUS-MB. Thus far, we do not understand exactly 1) whether CSF is drained mainly through the basal meningeal lymphatic vessels or evenly through dorsal/basal and spinal meningeal lymphatic vessels and 2) how much fraction of CSF is effluxed to each type of meningeal lymphatic vessels and 3) exact location of meningeal lymphatic vessels within the dura or across dura/arachnoid membrane or beneath the dura in the subarachnoid space. According to the recent report, basal meningeal lymphatic vessels were proposed to the main routes of disposal of CSF to lymphatic vessels, however, they used cisternal injection of MRI contrast agents or even quantum dots. The preferred routes of choosing basal meningeal lymphatic vessels might be taken granted by the basal cistern, the injection site. Therefore, various experimental results, such as injection site and dosage, will enlighten the contribution of the location/type of meningeal lymphatic vessels. Understanding this CSF-lymphatic clearance is still primitive and more facts are expected to be elucidated.
We administered FUS with MB targeted not to a small region, but to almost one-third of a hemisphere (Fig. 1a) , and we examined the effects of FUS-MB upon the brain-residing cells regarding gliosis and neuronal loss (Fig. 4) . After FUS, acute inflammation is known to take place with glial cell activation decreasing within 24 hours 20 . In this experiment, we examined gliosis a week after 4-or 6-times repeated FUS-MB and observed the decrease of overall decrease of Iba1 positive microglia in entire brain including dentate gyrus, CA1/CA3 hippocampus and entorhinal cortex compared to naïve 5XFAD (Fig. 4c) . FUS-MB also decreased GFAP positive activated astrocytes uniquely in entorhinal cortex after FUS-MB and did not in the other brain regions (Fig. 4b) . It is not yet known whether the decrease of gliosis regionally by activated astrocytes or globally by microglia after FUS-MB was due to its effect on microglia to decrease phagocytosis or due to the effect on Aβ reduction causing decrease of microglia and activated astrocytes. The effect of FUS-MB on neuronal death only appeared after dCLN ligation. Despite dCLN ligation, FUS-MB might have relieved harmful effect of Aβ on neurons, and naïve and FUS-MB treated 5XFAD mice did not reveal neurons dead (Fig. 4a ). We applied FUS-MB for wider areas than the previous FUS-MB BBB opening studies. Nevertheless, the neuronal death is expected to be caused by solute Aβ which was successfully drained by FUS-MB even after dCLN ligation.
In mice we used a model to facilitate efflux of harmful toxic solute which was supposed to be Aβ by FUS-MB and a model to block the drainage through meningeal lymphatics by dCLN ligation. The use of these models improved the contrast of the findings, and we could delineate the importance of improved amyloid clearance and restored memory in AD model mice by enhancing glymphatic-lymphatic clearance. In humans, phase 1 study showed no group differences on amyloid plaque burden on amyloid PET images after repeated FUS in five patients with AD 21 . Though, this negative result can be simply attributed to the difference between mouse and human 22 , there might be the confounders like the status of lymphatic drainage and many more factors affecting the progress of AD in humans. Roles of added MB were also suggested for effective FUS as MB were distributed in perivascular space, subarachnoid space, and surrounding large veins in patients with AD and ALS and thus might be assumed to have regulated glymphatic efflux by FUS 23 . We also consider the possibility that solute Aβ reduction through Aβ clearance would contribute only to the prevention during preclinical stage rather than established AD or the need for long-term follow-up to observe the preventive effect. Aβ burden should have been removed by FUS-MB before they had injured permanently the neurons and other brain-resident cells.
Taken together, glymphatic-lymphatic system of the brain plays a direct role in Aβ amyloid deposition and drainage, while FUS-MB restored memory by increasing amyloid drainage.
The structural changes of the meningeal lymphatic vessels with aging result in the functional 1 6 consequences of the glymphatic-lymphatic clearance of Aβ and other possible toxic solutes 24 , which is why ageing has become a major risk factor for AD. FUS-MB is a potential preventive measure against dysfunction of glymphatic-lymphatic system in prodromal or early AD. Furthermore, the effect of the current amyloid removal therapeutics, such as antibody therapy, might be enhanced by FUS-MB and should be accompanied or accompanied by clearance of toxic solutes already present or newly generated in the aging brain by antibody therapy. We emphasize that physiologic disposal from the brain parenchyma of the toxic solute macromolecules has the novel preventive and therapeutic possibility for neurodegenerative diseases associated with abnormal proteins such as tau, α -synuclein and TDP43 as well as Aβ. b. 30 minutes after Evans blue injection into cisterna magna, CSF and dCLN changed to blue.
On the other hand, after lCLN ligation, dCLN did not turn blue.
Materials and Methods
Animal models
The 5XFAD mice contain five FAD mutations in human APP and PS1, and age matched littermates were used as wild-type controls. One group was set up at the 4 months of age and FUS-MB were treated once a week for 6 weeks. After one week passed after the last FUS-MB, the animals were put to behavior test, sampling of CSF, sacrificed and brain specimen were harvested for pathological analysis. The other experimental groups received bilateral lymphatics ligation to dCLN at the age of 4 months. After two weeks of postoperative stabilization, FUS-MB was treated once a week for 4 weeks.
Again after one week, behavior test, sampling of CSF for and pathological analysis was performed including Aβ ELISA and Thioflavin S and immunostaining. In this study, all experiments were conducted with approval Institutional Animal Care and Use Committee at Seoul National University.
FUS-MB procedure
A total of 100 μ l MB (SonoVue ® , Bracco Suisse S.A., #701299) was infused through the tail vein during the sonication. At the center frequency of 715 kHz, the sonication was 60 s in duration and consisted of 20 ms bursts at a pulse repetition frequency of 1 Hz (2% duty cycle). Acoustic pressure at the targeted area was 0.42 MPa. Target region of sonication was determined by our house-made stereotaxic frame. After the sonication, 2% Evans blue at 200μl was intravenously administered to confirm the BBB opening.
dCLN ligation model
Mice were anesthetized with 2% isoflurane at 1L/min oxygen flow. And then, the incision site was shaved and sterilized. After longitudinal incision of the neck from the mandible to the sternum, the muscles and fascia were separated from the carotid artery under stereomicroscope. dCLN, located around the carotid artery, were carefully dissected from surrounding tissues and ligated with 9-0 nylon suture. After surgery, the animals were stabilized for two weeks. To confirm the ligation of lymphatics, 5μl of 2% Evans blue was injected into cisterna magna of mice. Without the ligation of dCLN, CSF and dCLN were stained blue 30 min after the Evans blue injection. But, after the ligation, dCLN was not stained blue ( Supplementary Fig. 1 ).
Y-maze test for memory
The Y-maze test was carried out one week after the last FUS-MB treatment to evaluate short-term working memory. Each mouse was placed at the center of Y-maze and allowed to move for 8 minutes.
Percentage alternation is the number of entries into three arms divided by the maximum possible alternations.
Enzyme-linked immunosorbent assay (ELISA) for Aβ
Mice were anesthetized with 2% isoflurane and 5μl of CSF was collected from CSF in cisterna magna.
CSF Aβ was measured with Human Aβ Ultrasensitive ELISA Kit (Invitrogen, #KHB3544).
Immunohistochemistry for Aβ and glia cells
Mice were perfused blood flow with cold 1X phosphate-buffered saline (PBS) and the whole brains were harvested with the skull attached. After carefully separating brains from the skull, the brains were coronally sectioned with 2 mm, embedded in paraffin embedded, and analyzed For the capture of stained slide, the LEICA confocal microscopy SP8 was used.
Thioflavin S staining for amyloid plaques
The paraffin embedded sections were deparaffinized in xylene and rehydrated in a series of graded ethanol solution. The hydrated brain sections were incubated in 1% filtered Thioflavin S solution for 8 minutes and washed with 70% ethanol and distilled water (DW). To quantify the Thioflavin S stained slice images, Image J software was used.
Hematoxylin and Eosin staining for brain
After deparaffinization and rehydration, sectioned brain tissues were stained with Harris hematoxylin for 30 seconds and washed with DW for 10 minutes. Next, the tissues were stained with eosin for 1 min, dehydrated and washed with xylene. Canada balsam was used for mounting.
TUNEL staining for brain
To detect apoptosis in brain tissue, DeadEnd TM Fluorometric TUNEL System (Promega, #G3250) was used. The above indexes were quantified according to the manufacturer's instructions. Briefly, the deparaffinized tissues were fixed and washed. And the tissues were incubated in 20ug/ml proteinase K to increase permeability. Next, the washed tissues were incubated in equilibration buffer and labelled with TdT reaction mixture at 37°C for 60 minutes. After the reaction, the slides were immersed in 2X SSC to stop the reaction and washed.
Statistical analysis
Data were statistically analyzed with Prism and Real Statistics/Excel softwares. Values were reported
